48 related articles for article (PubMed ID: 38518198)
1. Prognostic and clinical significance of VEGFR-3 in gastric cancer: A meta-analysis.
Ge H; Yan Y; Guo L; He X; Yang X
Clin Chim Acta; 2017 Nov; 474():114-119. PubMed ID: 28939099
[TBL] [Abstract][Full Text] [Related]
2. The pathological roles and potential mechanisms of vascular endothelial growth factor receptor-3 in gastric cancer.
Li XF; Zhang XJ; Hao FR; Dong XT; Xu GD; Zhang YX
J Int Med Res; 2024 Mar; 52(3):3000605241234558. PubMed ID: 38518198
[TBL] [Abstract][Full Text] [Related]
3. Xiaotan Sanjie decoction inhibits angiogenesis in gastric cancer through Interleukin-8-linked regulation of the vascular endothelial growth factor pathway.
Shi J; Lu Y; Wei P
J Ethnopharmacol; 2016 Aug; 189():230-7. PubMed ID: 27224240
[TBL] [Abstract][Full Text] [Related]
4. RNAi-mediated silencing of VEGF-C inhibits non-small cell lung cancer progression by simultaneously down-regulating the CXCR4, CCR7, VEGFR-2 and VEGFR-3-dependent axes-induced ERK, p38 and AKT signalling pathways.
Feng Y; Hu J; Ma J; Feng K; Zhang X; Yang S; Wang W; Zhang J; Zhang Y
Eur J Cancer; 2011 Oct; 47(15):2353-63. PubMed ID: 21680174
[TBL] [Abstract][Full Text] [Related]
5. MTMR2 promotes invasion and metastasis of gastric cancer via inactivating IFNγ/STAT1 signaling.
Jiang L; Liu JY; Shi Y; Tang B; He T; Liu JJ; Fan JY; Wu B; Xu XH; Zhao YL; Qian F; Cui YH; Yu PW
J Exp Clin Cancer Res; 2019 May; 38(1):206. PubMed ID: 31113461
[TBL] [Abstract][Full Text] [Related]
6. Nicotine induces cyclooxygenase-2 and vascular endothelial growth factor receptor-2 in association with tumor-associated invasion and angiogenesis in gastric cancer.
Shin VY; Wu WK; Chu KM; Wong HP; Lam EK; Tai EK; Koo MW; Cho CH
Mol Cancer Res; 2005 Nov; 3(11):607-15. PubMed ID: 16317086
[TBL] [Abstract][Full Text] [Related]
7. SPARC expression is negatively correlated with clinicopathological factors of gastric cancer and inhibits malignancy of gastric cancer cells.
Zhang J; Wang P; Zhu J; Wang W; Yin J; Zhang C; Chen Z; Sun L; Wan Y; Wang X; Chen G; Liu Y
Oncol Rep; 2014 May; 31(5):2312-20. PubMed ID: 24676680
[TBL] [Abstract][Full Text] [Related]
8. Molecular Mechanisms and Future Implications of VEGF/VEGFR in Cancer Therapy.
Patel SA; Nilsson MB; Le X; Cascone T; Jain RK; Heymach JV
Clin Cancer Res; 2023 Jan; 29(1):30-39. PubMed ID: 35969170
[TBL] [Abstract][Full Text] [Related]
9. Relationship between VEGF Family Members, Their Receptors and Cell Death in the Neoplastic Transformation of Colorectal Cancer.
Dakowicz D; Zajkowska M; Mroczko B
Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328794
[TBL] [Abstract][Full Text] [Related]
10. Gastric epithelial histology and precancerous conditions.
Yang H; Yang WJ; Hu B
World J Gastrointest Oncol; 2022 Feb; 14(2):396-412. PubMed ID: 35317321
[TBL] [Abstract][Full Text] [Related]
11. Regulation of VEGFR Signalling in Lymphatic Vascular Development and Disease: An Update.
Secker GA; Harvey NL
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299378
[TBL] [Abstract][Full Text] [Related]
12. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
Sung H; Ferlay J; Siegel RL; Laversanne M; Soerjomataram I; Jemal A; Bray F
CA Cancer J Clin; 2021 May; 71(3):209-249. PubMed ID: 33538338
[TBL] [Abstract][Full Text] [Related]
13. Gastric cancer: Epidemiology, risk factors and prevention strategies.
Yang L; Ying X; Liu S; Lyu G; Xu Z; Zhang X; Li H; Li Q; Wang N; Ji J
Chin J Cancer Res; 2020 Dec; 32(6):695-704. PubMed ID: 33446993
[TBL] [Abstract][Full Text] [Related]
14. Association Between Lymph Node Ratio and Survival in Patients with Pathological Stage II/III Gastric Cancer.
Kano K; Yamada T; Yamamoto K; Komori K; Watanabe H; Hara K; Shimoda Y; Maezawa Y; Fujikawa H; Aoyama T; Tamagawa H; Yamamoto N; Cho H; Shiozawa M; Yukawa N; Yoshikawa T; Morinaga S; Rino Y; Masuda M; Ogata T; Oshima T
Ann Surg Oncol; 2020 Oct; 27(11):4235-4247. PubMed ID: 32424582
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
